Latest Breaking News On - Surg oncol - Page 1 : comparemela.com

Vaccinex : ASCO Conference Presentation - MarketScreener

Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate PEPINEMAB IN COMBINATION WITH PEMBROLIZUMAB for first-linetreatment.

North carolinaUnited statesSan franciscoSan diegoJ thaddeus beckDouglas adkinsConor steuerNagashree seetharamuTulliac brunoTerrencel fisherEllen giampoliSteven hagerChristopher chayAlain algaziAmber fosterNabilf saba

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Sri lankaComunidad autonoma de catalunaPais vascoSouth koreaGastroenterol hepatolJ gastroenterol hepatolRev dis primersBarcelona clinicLiver cancerHepatocell carcinomaBarcelona clinic liver cancerSurg oncolTransl medEnglj medClin oncolResponse evaluation criteria in solid tumours

Women, power, and cancer: a Lancet Commission

Women, power, and cancer: a Lancet Commission
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKhorasane janubiJawa baratNigeria generalYedebub biheroch bihereseboch na hizbochSwitzerland generalCancer instituteAl qahirahWorld bankDistrict of columbiaIsrael generalFrance generalSouth koreaCity of san fernandoSouth africa

Vaccinex : ASCO Poster - PDAC study abstract # TPS4195

Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma Luis. | June 5, 2023

United statesJen yehLuis ruffoloJohne leonardMaurice zaudererElizabethe evansTerrencel fisherDavid linehanAmber fosterDaniel mulkerinMegan boiseUniversity of north carolina at chapel hillExchange commissionMerck kgaVaccinex incMerck kgaa

Thyroid cancer

The past 5–10 years have brought in a new era in the care of patients with thyroid cancer, with the introduction of transformative diagnostic and management options. Several international ultrasound-based thyroid nodule risk stratification systems have been developed with the goal of reducing unnecessary biopsies. Less invasive alternatives to surgery for low-risk thyroid cancer, such as active surveillance and minimally invasive interventions, are being explored. New systemic therapies are now available for patients with advanced thyroid cancer.

New caledonia generalNew caledoniaUnited statesNew zealandSri lankaJ clin endocrinolClin endocrinolElkrim saadAnn endocrinolJackson levinDal masoPublications office of the european commissionEuropean unionInstitut national de la statistiqueAmerican thyroid associationAmerican association of endocrine surgeons